Research square · 2026
Association between circadian rhythm sleep disorder and open-angle glaucoma: The modifying role of melatonin.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eleiwa Taher, Chauhan Muhammad, Kishor Krishna, Al Aref Subhi, Khodeiry Mohamed, Abboud Ibrahim, Bhattacharya Sanjoy, Lee Richard, Elhusseiny Abdelrahman
Аннотация
BACKGROUND: Circadian rhythm sleep disorders (CRSD) may disrupt neurovascular regulation and increase open-angle glaucoma (OAG) and ocular hypertension (OHT) risk. This study assessed associations with OAG, primary open-angle glaucoma (POAG), and OHT and examined melatonin's modifying effect.
METHODS: A retrospective cohort study using TriNetX data included adults (≥ 18 years) with CRSD matched 1:1 to polysomnography-tested controls without sleep disorders. Melatonin subgroups were analyzed. Among 24,730 matched pairs, ICD-10-defined OAG, POAG, and OHT at 1, 3, and 5 years were assessed using adjusted hazard ratios (aHRs) and Kaplan-Meier analyses.
RESULTS: After matching, 24,730 patients were included in each group. The CRSD group had a significantly higher risk of OAG at 1 year (0.14% vs. 0.04%; P=.0005; aHR 2.67, 95% CI 1.42-5.02), 3 years (0.25% vs. 0.07%; P < .0001; aHR 3.02, 95% CI 1.81-5.05), and 5 years (0.27% vs. 0.08%; P < .0001; aHR 2.88, 95% CI 1.78-4.66). Similar trends were observed for POAG, while no significant differences were seen for OHT. Among CRSD patients not using melatonin (n = 24,150 pairs), OAG risk remained significantly elevated at all time points. In contrast, among melatonin users (n = 4,081 pairs), the risks of OAG, and OHT were not significantly different from controls (5-year OAG: 0.52% vs. 0.32%; P = .23; aHR 2.07, 95% CI 0.88-4.84).
CONCLUSIONS: CRSD is associated with an increased risk of OAG and POAG, in patients not using melatonin. Melatonin use appears to decrease this risk, suggesting a potential protective effect.
METHODS: A retrospective cohort study using TriNetX data included adults (≥ 18 years) with CRSD matched 1:1 to polysomnography-tested controls without sleep disorders. Melatonin subgroups were analyzed. Among 24,730 matched pairs, ICD-10-defined OAG, POAG, and OHT at 1, 3, and 5 years were assessed using adjusted hazard ratios (aHRs) and Kaplan-Meier analyses.
RESULTS: After matching, 24,730 patients were included in each group. The CRSD group had a significantly higher risk of OAG at 1 year (0.14% vs. 0.04%; P=.0005; aHR 2.67, 95% CI 1.42-5.02), 3 years (0.25% vs. 0.07%; P < .0001; aHR 3.02, 95% CI 1.81-5.05), and 5 years (0.27% vs. 0.08%; P < .0001; aHR 2.88, 95% CI 1.78-4.66). Similar trends were observed for POAG, while no significant differences were seen for OHT. Among CRSD patients not using melatonin (n = 24,150 pairs), OAG risk remained significantly elevated at all time points. In contrast, among melatonin users (n = 4,081 pairs), the risks of OAG, and OHT were not significantly different from controls (5-year OAG: 0.52% vs. 0.32%; P = .23; aHR 2.07, 95% CI 0.88-4.84).
CONCLUSIONS: CRSD is associated with an increased risk of OAG and POAG, in patients not using melatonin. Melatonin use appears to decrease this risk, suggesting a potential protective effect.